GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Waters Corp (FRA:WAZ) » Definitions » EV-to-EBIT

Waters (FRA:WAZ) EV-to-EBIT : 24.69 (As of Apr. 25, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Waters EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Waters's Enterprise Value is €19,104 Mil. Waters's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €774 Mil. Therefore, Waters's EV-to-EBIT for today is 24.69.

The historical rank and industry rank for Waters's EV-to-EBIT or its related term are showing as below:

FRA:WAZ' s EV-to-EBIT Range Over the Past 10 Years
Min: 14.52   Med: 20.37   Max: 33.19
Current: 24.48

During the past 13 years, the highest EV-to-EBIT of Waters was 33.19. The lowest was 14.52. And the median was 20.37.

FRA:WAZ's EV-to-EBIT is ranked worse than
57.01% of 107 companies
in the Medical Diagnostics & Research industry
Industry Median: 20.2 vs FRA:WAZ: 24.48

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Waters's Enterprise Value for the quarter that ended in Dec. 2023 was €19,629 Mil. Waters's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €774 Mil. Waters's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 3.94%.


Waters EV-to-EBIT Historical Data

The historical data trend for Waters's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waters EV-to-EBIT Chart

Waters Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.09 24.89 27.80 24.17 25.78

Waters Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.17 22.28 20.88 21.57 25.78

Competitive Comparison of Waters's EV-to-EBIT

For the Diagnostics & Research subindustry, Waters's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Waters's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Waters's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Waters's EV-to-EBIT falls into.



Waters EV-to-EBIT Calculation

Waters's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=19104.482/773.738
=24.69

Waters's current Enterprise Value is €19,104 Mil.
Waters's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €774 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Waters  (FRA:WAZ) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Waters's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=773.738/19629.248
=3.94 %

Waters's Enterprise Value for the quarter that ended in Dec. 2023 was €19,629 Mil.
Waters's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €774 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Waters EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Waters's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Waters (FRA:WAZ) Business Description

Traded in Other Exchanges
Address
34 Maple Street, Milford, MA, USA, 01757
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2022, Waters generated 59% from pharmaceutical customers, 31% from industrial clients, and 10% from academic/government institutions.

Waters (FRA:WAZ) Headlines

No Headlines